Copy number variant study of bipolar disorder in Canadian and UK populations implicates synaptic genes
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Genome‐wide single nucleotide polymorphism (SNP) data from 936 bipolar disorder (BD) individuals and 940 psychiatrically healthy comparison individuals of North European descent were analyzed for copy number variation (CNV). Using multiple CNV calling algorithms, and validating using in vitro molecular analyses, we identified CNVs implicating several candidate genes that encode synaptic proteins, such as DLG1,DLG2,DPP6,NRXN1,NRXN2,NRXN3,SHANK2, and EPHA5, as well as the neuronal splicing regulator RBFOX1(A2BP1), and neuronal cell adhesion molecule CHL1. We have also identified recurrent CNVs on 15q13.3 and 16p11.2‐regions previously reported as risk loci for neuropsychiatric disorders. In addition, we performed CNV analysis of individuals from 215 BD trios and identified de novo CNVs involving the NRXN1 and DRD5 genes. Our study provides further evidence of the occasional involvement of genomic mutations in the etiology of BD, however, there is no evidence of an increased burden of CNVs in BD. Further, the identification of CNVs at multiple members of the neurexin gene family in BD individuals, supports the role of synaptic disruption in the etiology of BD. © 2014 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Strong association of de novo copy number mutations with autism
Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., et al. (2007) · Science · doi:10.1126/science.1138659 · Cited by 2,795 · cited 1×
“Increased burden of CNVs has been reported for neuropsychiatric disorders including autism [Sebat et al., 2007; Pinto et al., 2010; Sanders et al., 2011] and SCZ [International Schizophrenia Consortium, 2008; Walsh et al., 2008; Kirov et al., 2009; Sebat et al., 2009; Buizer-Voskamp et al., 2011].”
BackgroundSCAN: Schedules fonr Clinical Assessment in Neuropsychiatry
Wing, J. K. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810180089012 · Cited by 2,517 · cited 1×
“SCANwasdeveloped in the framework of the World Health Organisation (WHO) and the National Institutes of Health (NIH) Joint Project on Diagnosis and Classification of Mental Disorders Alcohol and Drug Related Problems [Wing et al., 1990].”
MethodLichtenstein, P., Yip, B. H., Björk, C., Pawitan, Y., Cannon, T. D., Sullivan, P. F., & Hultman, C. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60072-6 · Cited by 2,125
Functional impact of global rare copy number variation in autism spectrum disorders
Pinto, D., Pagnamenta, A. T., Klei, L., Anney, R., Merico, D., Regan, R., Conroy, J., Magalhaes, T. R., Correia, C., Abrahams, B. S., et al. (2010) · Nature · doi:10.1038/nature09146 · Cited by 2,013 · cited 5×
“Quality control and CNV analysis for the Illumina Hap550 duo data were performed using previously described methods [Pinto et al., 2010].”
BackgroundMethodInfluentialSelf-citationStructural Variation of Chromosomes in Autism Spectrum Disorder
Marshall, C. R., Noor, A., Vincent, J. B., Lionel, A. C., Feuk, L., Skaug, J., Shago, M., Moessner, R., Pinto, D., Ren, Y., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.12.009 · Cited by 1,815 · cited 3×
“Other validated CNVs of note in this study include a gain in DPP6, duplicating the first exon, also reported in autism and ADHD [Marshall et al., 2008; Elia et al., 2010], and a deletion of the first coding exon of LARGE, also seen in one control; also reported in ASD, BD, and SCZ [Walsh et al.,…”
BackgroundMethodSelf-citationRare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia
Walsh, T., McClellan, J. M., McCarthy, S. E., Addington, A. M., Pierce, S. B., Cooper, G. M., Nord, A. S., Kusenda, M., Malhotra, D., Bhandari, A., et al. (2008) · Science · doi:10.1126/science.1155174 · Cited by 1,800
Wang, K., Li, M., Hadley, D., Liu, R., Glessner, J., Grant, S. F. A., Hakonarson, H., & Bucan, M. (2007) · Genome Research · doi:10.1101/gr.6861907 · Cited by 1,792
McGuffin, P. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810320088015 · Cited by 1,483
Self-citationRare chromosomal deletions and duplications increase risk of schizophrenia
The International Schizophrenia Consortium (2008) · Nature · doi:10.1038/nature07239 · Cited by 1,475
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes
Glessner, J. T., Wang, K., Cai, G., Korvatska, O., Kim, C. E., Wood, S., Zhang, H., Estes, A., Brune, C. W., Bradfield, J. P., et al. (2009) · Nature · doi:10.1038/nature07953 · Cited by 1,421
Sanders, S. J., Ercan-Sencicek, A. G., Hus, V., Luo, R., Murtha, M. T., Moreno-De-Luca, D., Chu, S. H., Moreau, M. P., Gupta, A. R., Thomson, S. A., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.002 · Cited by 1,263
Strong association of de novo copy number mutations with sporadic schizophrenia
Xu, B., Roos, J. L., Levy, S., van Rensburg, E. J., Gogos, J. A., & Karayiorgou, M. (2008) · Nature Genetics · doi:10.1038/ng.162 · Cited by 813
Korn, J. M., Kuruvilla, F. G., McCarroll, S. A., Wysoker, A., Nemesh, J., Cawley, S., Hubbell, E., Veitch, J., Collins, P. J., Darvishi, K., et al. (2008) · Nature Genetics · doi:10.1038/ng.237 · Cited by 783 · cited 1×
“…contrast, a study of European American BD cases and controls analyzed CNVs from Affymetrix 6.0 data on 1,001 BD and 1,033 controls using Birdsuite [Korn et al., 2008], and showed a significant enrichmentof “singleton” (CNVevents occurringonce in adataset) deletions in BD cases versus controls…”
ResultInfluentialDisruption of the neurexin 1 gene is associated with schizophrenia
Rujescu, D., Ingason, A., Cichon, S., Pietiläinen, O. P. H., Barnes, M. R., Toulopoulou, T., Picchioni, M., Vassos, E., Ettinger, U., Bramon, E., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn351 · Cited by 471
Support for the involvement of large copy number variants in the pathogenesis of schizophrenia.
Kirov, G., Grozeva, D., Norton, N., Ivanov, D., Mantripragada, K. K., Holmans, P., International Schizophrenia Consortium, the Wellcome Trust Case Control Consortium, Craddock, N., Owen, M. J., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp043 · Cited by 390
Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia
Kirov, G., Gumus, D., Chen, W., Norton, N., Georgieva, L., Sari, M., O'Donovan, M. C., Erdogan, F., Owen, M. J., Ropers, H.-H., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm323 · Cited by 377 · cited 2×
“Focussingon specific genes,CNVs inNRXN1have been reported for SCZ, autism, language delay, and intellectual disability [Kirov et al., 2008; Vrijenhoek et al., 2008; Need et al., 2009; Rujescu et al., 2009; Ching et al., 2010; Shah et al., 2010; Gregor et al., 2011; Duong et al., 2012], as well as frameshift and missen…”
BackgroundThe splicing regulator Rbfox1 (A2BP1) controls neuronal excitation in the mammalian brain
Gehman, L. T., Stoilov, P., Maguire, J., Damianov, A., Lin, C.-H., Shiue, L., Ares, M., Mody, I., & Black, D. L. (2011) · Nature Genetics · doi:10.1038/ng.841 · Cited by 331 · cited 1×
“…is a neuron-specific splicing factor, and has been shown in mouse knockout experiments to be involved in controlling synaptic transmission and membrane excitation [Gehman et al., 2011], as well as regulating splicing innetworks important inneuronal development and maturation [Fogel et al., 2012].”
BackgroundHigh frequencies of de novo CNVs in bipolar disorder and schizophrenia
Malhotra, D., McCarthy, S., Michaelson, J. J., Vacic, V., Burdick, K. E., Yoon, S., Cichon, S., Corvin, A., Gary, S., Gershon, E. S., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.11.007 · Cited by 325
Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia
Gauthier, J., Siddiqui, T. J., Huashan, P., Yokomaku, D., Hamdan, F. F., Champagne, N., Lapointe, M., Spiegelman, D., Noreau, A., Lafrenière, R. G., et al. (2011) · Human Genetics · doi:10.1007/s00439-011-0975-z · Cited by 286 · cited 2×
“…Need et al., 2009; Rujescu et al., 2009; Ching et al., 2010; Shah et al., 2010; Gregor et al., 2011; Duong et al., 2012], as well as frameshift and missense mutations [Gauthier et al., 2011], and represents one of the most consistent and replicable genomic findings in neuropsychiatric genetics.”
BackgroundRBFOX1 regulates both splicing and transcriptional networks in human neuronal development
Fogel, B. L., Wexler, E., Wahnich, A., Friedrich, T., Vijayendran, C., Gao, F., Parikshak, N., Konopka, G., & Geschwind, D. H. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds240 · Cited by 216 · cited 2×
“…is a neuron-specific splicing factor, and has been shown in mouse knockout experiments to be involved in controlling synaptic transmission and membrane excitation [Gehman et al., 2011], as well as regulating splicing innetworks important inneuronal development and maturation [Fogel et al., 2012].”
BackgroundCytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism
Martin, C. L., Duvall, J. A., Ilkin, Y., Simon, J. S., Arreaza, M. G., Wilkes, K., Alvarez‐Retuerto, A., Whichello, A., Powell, C. M., Rao, K., et al. (2007) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30530 · Cited by 198 · cited 4×
“CNVs and cytogenetic aberrations have been reported overlappingRBFOX1, also knownasA2BP1 (ataxin 2 binding protein 1) in ASD [Martin et al., 2007; Davis et al., 2012], SCZ [Melhem et al., 2011], attention-deficit hyperactivity disorder (ADHD) [Elia et al., 2010], and in intellectual disability and…”
BackgroundInfluentialGrozeva, D. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.25 · Cited by 192 · cited 2×
“However, a similar study, also looking at the WTCCC data, compared frequency and number of CNVs across disorders, and reported that, while the burden of CNVs is elevated in schizophrenia (SCZ), the CNV burden in BD was not increased in comparison to controls [Grozeva et al., 2010].”
ResultSingleton deletions throughout the genome increase risk of bipolar disorder
Zhang, D., Cheng, L., Qian, Y., Alliey-Rodriguez, N., Kelsoe, J. R., Greenwood, T., Nievergelt, C., Barrett, T. B., McKinney, R., Schork, N., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.144 · Cited by 148 · cited 4×
“…et al., 2010; Pagnamenta et al., 2010; Patel et al., 2011], as well as CNVs in autism [Maestrini et al., 2010; Pagnamenta et al., 2010], ADHD [Elia et al., 2010], dyslexia [Girirajan et al., 2011], Alzheimer’s disease [Swaminathan et al., 2012], andBD [Zhang et al., 2009; Priebe et al., 2012].”
BackgroundMethodResultInfluentialBhalla, K., Phillips, H. A., Crawford, J., McKenzie, O. L. D., Mulley, J. C., Eyre, H., Gardner, A. E., Kremmidiotis, G., & Callen, D. F. (2004) · Journal of Human Genetics · doi:10.1007/s10038-004-0145-4 · Cited by 146 · cited 2×
“…have been reported overlappingRBFOX1, also knownasA2BP1 (ataxin 2 binding protein 1) in ASD [Martin et al., 2007; Davis et al., 2012], SCZ [Melhem et al., 2011], attention-deficit hyperactivity disorder (ADHD) [Elia et al., 2010], and in intellectual disability and epilepsy [Bhalla et al., 2004].”
BackgroundIMGSAC, Maestrini, E., Pagnamenta, A. T., Lamb, J. A., Bacchelli, E., Sykes, N. H., Sousa, I., Toma, C., Barnby, G., Butler, H., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.34 · Cited by 143
Confirmed rare copy number variants implicate novel genes in schizophrenia
Tam, G. W. C., van de Lagemaat, L. N., Redon, R., Strathdee, K. E., Croning, M. D. R., Malloy, M. P., Muir, W. J., Pickard, B. S., Deary, I. J., Blackwood, D. H. R., et al. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380445 · Cited by 139 · cited 1×
“A translocation and deletion at CHL1 have previously been linked to intellectual disability [Angeloni et al., 1999; Frints et al., 2003], as well as to SCZ [Tam et al., 2010].”
BackgroundPagnamenta, A. T., Bacchelli, E., de Jonge, M. V., Mirza, G., Scerri, T. S., Minopoli, F., Chiocchetti, A., Ludwig, K. U., Hoffmann, P., Paracchini, S., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.02.002 · Cited by 139 · cited 2×
“…[Petek et al., 2001; Maestrini et al., 2010; Pagnamenta et al., 2010; Patel et al., 2011], as well as CNVs in autism [Maestrini et al., 2010; Pagnamenta et al., 2010], ADHD [Elia et al., 2010], dyslexia [Girirajan et al., 2011], Alzheimer’s disease [Swaminathan et al., 2012], andBD [Zhang…”
BackgroundExpanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1
Gregor, A., Albrecht, B., Bader, I., Bijlsma, E. K., Ekici, A. B., Engels, H., Hackmann, K., Horn, D., Hoyer, J., Klapecki, J., et al. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-106 · Cited by 121 · cited 2×
“…disability [Kirov et al., 2008; Vrijenhoek et al., 2008; Need et al., 2009; Rujescu et al., 2009; Ching et al., 2010; Shah et al., 2010; Gregor et al., 2011; Duong et al., 2012], as well as frameshift and missense mutations [Gauthier et al., 2011], and represents one of the most…”
BackgroundPriebe, L., Degenhardt, F. A., Herms, S., Haenisch, B., Mattheisen, M., Nieratschker, V, Weingarten, M., Witt, S., Breuer, R., Paul, T., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.8 · Cited by 84 · cited 3×
“…et al., 2010; Pagnamenta et al., 2010; Patel et al., 2011], as well as CNVs in autism [Maestrini et al., 2010; Pagnamenta et al., 2010], ADHD [Elia et al., 2010], dyslexia [Girirajan et al., 2011], Alzheimer’s disease [Swaminathan et al., 2012], andBD [Zhang et al., 2009; Priebe et al., 2012].”
BackgroundResultBuizer-Voskamp, J. E., Muntjewerff, J.-W., Strengman, E., Sabatti, C., Stefansson, H., Vorstman, J. A. S., & Ophoff, R. A. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.015 · Cited by 68 · cited 2×
“CNVs may also be relevant for other highly heritable complex disease such as SCZ [International Schizophrenia Consortium, 2008;Walsh et al., 2008; Kirov et al., 2009; Sebat et al., 2009; Buizer-Voskamp et al., 2011], ADHD [Elia et al., 2010; Jarick et al., 2014], and for BD.”
Background
Cited by
Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia
Genovese, G., Fromer, M., Stahl, E. A., Ruderfer, D. M., Chambert, K., Landén, M., Moran, J. L., Purcell, S. M., Sklar, P., Sullivan, P. F., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4402 · Cited by 444
Phenotypic spectrum of NRXN1 mono‐ and bi‐allelic deficiency: A systematic review
Castronovo, P., Baccarin, M., Ricciardello, A., Picinelli, C., Tomaiuolo, P., Cucinotta, F., Frittoli, M., Lintas, C., Sacco, R., & Persico, A. M. (2020) · Clinical Genetics · doi:10.1111/cge.13537 · Cited by 65
Genomic Disorders in Psychiatry-What Does the Clinician Need to Know?
Lowther, C., Costain, G., Baribeau, D. A., & Bassett, A. S. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0831-5 · Cited by 41
Ciuculete, D. M., Voisin, S., Kular, L., Jonsson, J., Rask-Andersen, M., Mwinyi, J., & Schiöth, H. B. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00884-8 · Cited by 35
Rare copy number variation in extremely impulsively violent males
Vevera, J., Zarrei, M., Hartmannová, H., Jedličková, I., Mušálková, D., Přistoupilová, A., Oliveriusová, P., Trešlová, H., Nosková, L., Hodaňová, K., et al. (2019) · Genes, Brain and Behavior · doi:10.1111/gbb.12536 · Cited by 15
Self-citation
Metadata
- Authors
- Noor, A., Lionel, A. C., Cohen‐Woods, S., Moghimi, N., Rucker, J., Fennell, A., Thiruvahindrapuram, B., Kaufman, L., Degagne, B., Wei, J., Parikh, S. V., Muglia, P., Forte, J., Scherer, S. W., Kennedy, J. L., Xu, W., McGuffin, P., Farmer, A., Strauss, J., & Vincent, J. B.
- Venue
- American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Publisher
- Wiley
- Published
- 2014-04-03
- Volume
- 165
- Issue
- 4
- Pages
- 303-313
- ISSN
- 1552-4841 (ISSN-L)
- 1552-485X
- OpenAlex
- W2064234593
- Cited by
- 79
- References
- 30
- FWCI
- 5.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.